X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (366) 366
Publication (44) 44
Book Chapter (7) 7
Book Review (6) 6
Conference Proceeding (1) 1
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (218) 218
breast cancer (195) 195
humans (172) 172
oncology (165) 165
female (150) 150
esr1 mutations (138) 138
cancer (112) 112
mutation (106) 106
esr1 protein (93) 93
esr1 (85) 85
breast neoplasms - genetics (76) 76
estrogen receptor alpha - genetics (76) 76
genetic aspects (75) 75
estrogen (73) 73
tumors (69) 69
gene expression (67) 67
metastasis (65) 65
genes (62) 62
research (61) 61
deoxyribonucleic acid--dna (52) 52
analysis (50) 50
breast neoplasms - pathology (50) 50
endocrine therapy (48) 48
medicine (47) 47
middle aged (47) 47
care and treatment (46) 46
therapy (45) 45
article (43) 43
circulating tumor dna (42) 42
expression (42) 42
genomes (42) 42
estrogen-receptor-alpha (40) 40
fulvestrant (39) 39
health aspects (39) 39
endocrine resistance (38) 38
multidisciplinary sciences (38) 38
adult (37) 37
development and progression (37) 37
dna (37) 37
research article (37) 37
breast (35) 35
breast neoplasms - drug therapy (35) 35
metastases (35) 35
postmenopausal women (35) 35
science (35) 35
studies (34) 34
animals (33) 33
genetics (33) 33
genomics (33) 33
risk factors (33) 33
cell-free dna (32) 32
estrogen receptors (32) 32
patients (32) 32
tamoxifen (32) 32
estrogen receptor (31) 31
breast neoplasms - metabolism (30) 30
genetic predisposition to disease (30) 30
male (30) 30
mutations (30) 30
resistance (30) 30
aged (29) 29
cell biology (29) 29
prognosis (29) 29
pathology (28) 28
polymorphism, single nucleotide (28) 28
breast-cancer (27) 27
proteins (27) 27
heterogeneity (26) 26
neoplasms. tumors. oncology. including cancer and carcinogens (26) 26
survival (26) 26
biomarkers (25) 25
estrogen-receptor (25) 25
case-control studies (24) 24
double-blind (24) 24
kinases (24) 24
risk (24) 24
diagnosis (23) 23
dna methylation (23) 23
erbb-2 protein (23) 23
genetic research (23) 23
polymorphism (23) 23
biochemistry & molecular biology (22) 22
biology (22) 22
cancer therapies (22) 22
genetics & heredity (22) 22
neoplasm metastasis (22) 22
p53 protein (22) 22
review (22) 22
single-nucleotide polymorphism (22) 22
alleles (21) 21
biomarkers, tumor - genetics (21) 21
cell line, tumor (21) 21
medical research (21) 21
metastatic breast cancer (21) 21
er-alpha (20) 20
gene frequency (20) 20
medicine & public health (20) 20
plasma (20) 20
receptors (20) 20
receptors, estrogen - metabolism (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 03/2017, Volume 116, Issue 6, pp. 726 - 730
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 20, pp. 6086 - 6093
Journal Article
Modern Pathology, ISSN 0893-3952, 02/2019, Volume 32, Issue 2, pp. 280 - 289
Journal Article
International Journal of Cancer, ISSN 0020-7136, 11/2015, Volume 137, Issue 10, pp. 2513 - 2519
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-542X, 02/2019, Volume 21, Issue 1, pp. 22 - 11
BackgroundBreast cancer is the most common invasive cancer among women worldwide. Next-generation sequencing (NGS) has revolutionized the study of cancer... 
Tumor burden | Clinical utility | CIRCULATING TUMOR DNA | ONCOLOGY | LANDSCAPE | ESR1 MUTATIONS | Breast cancer | Targeted sequencing | ctDNA | GENOME | CELL-FREE DNA | Analysis | Genetic aspects | Metastasis | Diagnosis | Genetic screening | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0136407
Journal Article
Expert Review of Molecular Diagnostics, ISSN 1473-7159, 07/2019, Volume 19, Issue 7, pp. 599 - 611
: In hormone receptor-positive breast cancer, mutations have emerged as a key mechanism of resistance to endocrine therapy. : Here, we review currently... 
mutation | breast cancer | SERD | hormone receptor | ESR1 | PATHOLOGY | ACQUIRED ENDOCRINE RESISTANCE | PLASMA | THERAPY | CIRCULATING TUMOR DNA | ESTROGEN-RECEPTOR-ALPHA | GENE AMPLIFICATION | INHIBITOR | AROMATASE | CELL-FREE DNA | CLINICAL-SIGNIFICANCE
Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 03/2017, Volume 7
Hormone receptor-positive breast cancer is the most frequent breast cancer subtype. Endocrine therapy (ET) targeting the estrogen receptor (ER) pathway... 
metastatic disease | endocrine resistance | breast neoplasms | ENDOCRINE THERAPY | ESR1 | CANCER | ESTROGEN-RECEPTOR | HETEROGENEITY | PALBOCICLIB | mutations | CIRCULATING TUMOR DNA | ONCOLOGY | FULVESTRANT | RESISTANCE | POSTMENOPAUSAL WOMEN | INHIBITOR
Journal Article
Journal Article